BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Position in AGIO — Agios Pharmaceuticals, Inc.
CIK 1520354
Paris, I0
Position in AGIO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$47,502,431
-$5,977,385 QoQ
Shares Held
1,280,044
-19.0% QoQ
Ownership
2.14%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#14
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,249,299,463 across 137 Biotechnology names. AGIO ranks #15 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
897,893 | $446,010,389 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
331,560 | $206,740,921 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
799,297 | $192,606,596 | |
| 4 | ARGX |
Argenx SE
|
121,786 | $112,989,396 | |
| 5 | INCY |
Incyte Corp
|
937,763 | $106,304,813 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
1,290,731 | $77,908,522 | |
| 7 | VCEL |
Vericel Corp
|
1,639,988 | $72,963,065 | |
| 8 | CYTK |
Cytokinetics Inc
|
827,810 | $70,521,132 |
All Filings in AGIO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,502,431 | 1,280,044 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $53,479,816 | 1,580,840 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $37,039,069 | 1,360,730 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $39,631,787 | 987,339 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $33,821,794 | 1,016,891 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $30,053,566 | 1,025,719 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $30,960,330 | 942,189 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $40,299,964 | 907,044 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $39,289,866 | 911,175 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $32,415,844 | 1,108,613 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $23,304,664 | 1,046,460 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $24,809,474 | 1,002,403 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $26,288,294 | 928,259 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $23,580,703 | 1,026,587 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $28,525,882 | 1,015,879 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $26,171,160 | 925,430 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $19,841,218 | 894,958 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $27,885,342 | 957,930 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $28,279,474 | 860,343 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $36,939,106 | 800,414 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $44,355,834 | 804,860 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $40,906,729 | 792,152 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $31,027,659 | 716,078 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $14,357,770 | 410,222 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $18,702,383 | 349,708 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $14,887,337 | 419,598 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||